Disclosure: Some links on this page are affiliate links, and each one is marked “sponsored.” If you use one, we may earn a commission at no cost to you. It never changes what Medicare, Cigna, or your plan covers. The $50 Medicare path on this page has no affiliate link at all.
Short answer: Cigna does not run a Cigna BALANCE Model GLP-1 program. The live $50 option is the separate Medicare GLP-1 Bridge. It can apply to eligible people with Medicare Part D, including some former Cigna Medicare members now with HealthSpring. Cigna work and Marketplace plans follow their own rules. Medicaid depends on whether the state joins BALANCE.
What changes your answer: five things. Do you have Medicare drug coverage? Why is the drug being prescribed? What was your BMI when you started treatment? Which exact drug and form were prescribed? And are you following an ongoing diet and activity plan?
One more thing. If your card used to say “Cigna Medicare,” take another look. Your 2026 card may say HealthSpring. That one detail changes who handles your regular drug coverage, and it is the first thing we will untangle below.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
This page is for you if:
- Your card or pharmacy app says Cigna, Express Scripts, Evernorth, or HealthSpring
- You had Cigna Medicare and now see the name HealthSpring
- You heard Medicare now covers some weight-management GLP-1s for $50 and want to know if you count
- You work for Cigna and lost weight-loss GLP-1 coverage on July 1, 2026
This page is not for you if:
- You want a list of telehealth companies that work with commercial Cigna plans. Go to GLP-1 Providers That Accept Cigna.
- You want the full federal story of BALANCE. Go to CMS BALANCE Model GLP-1 Explained.
- You want Cigna's full drug-by-drug coverage guide. Go to What GLP-1 Does Cigna Cover?.
What we checked for this page (September 24, 2026): CMS's BALANCE page and Medicare GLP-1 Bridge materials, Medicare.gov, Cigna's SEC filing on its Medicare sale, HealthSpring's own site, Cigna's September 2026 Foundayo policy, Evernorth's program pages, Cigna's public statement about its employee plan, and current Ro, NovoCare, Lilly, and Sesame pricing. We did not check your personal plan. Only your plan can confirm your benefit. The full list is at the bottom.
Which Cigna GLP-1 lane are you in?
The word “Cigna” does not decide your GLP-1 coverage. The type of plan does. Eligible Medicare drug plans can point to the $50 Medicare GLP-1 Bridge for qualifying weight-management prescriptions. Work and Marketplace plans follow their own drug rules. Medicaid depends on your state.
Find the row that matches your card. That row is your lane.
The RX Index Cigna GLP-1 Lane Matrix · verified September 24, 2026
| If your card or plan says… | Your GLP-1 lane | What you may pay | Your first move |
|---|---|---|---|
| HealthSpring PDP or Medicare Advantage plan with drug coverage, or an eligible plan that used to say Cigna Medicare | Medicare GLP-1 Bridge for a qualifying weight-management prescription; regular Part D for a covered medical use | Bridge: $50 for a 28- or 30-day supply if approved; Part D: your plan cost | Ask your prescriber which claim lane fits the reason for your prescription |
| A former employer's name + Medicare on a retiree drug plan | The Bridge may apply if the plan includes an eligible Medicare Part D benefit | Bridge: $50 if approved | Confirm that the retiree plan is an eligible Part D plan, then follow the Bridge process |
| Medicare, and the drug is prescribed for type 2 diabetes, qualifying sleep apnea, qualifying MASH, or an FDA-approved heart-risk use | Your regular Medicare drug plan | Your plan's copay or coinsurance | Use your Part D plan's normal prior-authorization process |
| Medicare, but no Part D or other eligible Medicare drug coverage | Not eligible for the Bridge right now | Not applicable | Review drug-plan enrollment options during an eligible enrollment period |
| Cigna or Express Scripts through work or the Marketplace | Your plan's own rules, not BALANCE | Your plan cost; up to $200 only if your employer added Evernorth's cap; or cash | Confirm that your plan covers weight-loss drugs before paying a provider |
| Cigna Group Medical Plan because you work for Cigna | Weight-loss GLP-1 coverage ended July 1, 2026; other covered uses follow the plan | Plan cost for a covered use, or cash if excluded | Check the reason for treatment first, then compare current FDA-approved cash options if needed |
| Your state's Medicaid program | Your state's rules; BALANCE matters only if your state participates | Depends on your state | Ask the state Medicaid agency for the current weight-management GLP-1 policy |
Sources: CMS Bridge provider information, CMS Bridge pharmacy information, CMS BALANCE Model, Evernorth's $200 benefit option, and Cigna's employee-plan statement reported by WFSB.
The 60-second self-check
- Do you have Medicare drug coverage? Look for Medicare Part D, PDP, MA-PD, or a Medicare retiree drug plan. No? Skip to the work-plan section. Yes? Keep going.
- Why is the GLP-1 being prescribed? For qualifying weight management? The Bridge may be your lane. For type 2 diabetes, moderate-to-severe obstructive sleep apnea, qualifying MASH, or an FDA-approved heart-risk use? Your regular drug plan is the right lane.
- What was your BMI when you started? Use today's BMI only if you have not started GLP-1 treatment. Is it 35 or more? Or 30 or more with a listed heart, blood-pressure, or kidney problem? Or 27 or more with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease? A match means you may qualify.
- Which exact drug and form were prescribed? Wegovy injection or tablet, Foundayo, or Zepbound KwikPen? Those are Bridge products. Other products and forms are not.
- Are you following an ongoing diet and activity plan? CMS requires the medicine to be used with ongoing lifestyle changes.
If all five points line up, your next step is a visit with your prescriber—not a call asking Cigna to opt in.
Not sure which row is yours? Get my personalized action plan →
The RX Index's Find My GLP-1 Path tool asks about your plan, your medicine, and your reason for treatment. Then it shows your likely lane and the next questions to ask. It is free, takes about 2 minutes, and needs no signup.
The right GLP-1 provider is not the same for everyone—it depends on your state, your insurance and formulary, whether you want an FDA-approved medicine or are considering a compounded option, your preferred form (injection or oral), and your budget. Because a general answer cannot resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. Compounded drugs are not FDA-approved, and the tool keeps those treatment paths separate from FDA-approved brands.
What does “Cigna BALANCE Model GLP-1” actually mean?
It is a mix-up of separate programs. The BALANCE Model is a voluntary program run by CMS, the federal agency over Medicare and Medicaid, and Cigna does not run it. The live $50 program is a different CMS program called the Medicare GLP-1 Bridge.
Here are the five names people are blending together:
| Name | What it is | Who runs it | Does it affect your GLP-1? |
|---|---|---|---|
| BALANCE Model | A federal model built around negotiated terms for select weight-management GLP-1s in Medicaid and, potentially later, Medicare Part D | CMS | Medicaid: only in participating states. Medicare Part D: CMS did not launch BALANCE for 2027. |
| Medicare GLP-1 Bridge | A temporary federal demonstration with a $50 copay for specified products | CMS, with Humana as the central processor | Yes, if you have eligible Medicare drug coverage and meet every rule. It runs July 1, 2026, through December 31, 2027. |
| Cigna Healthcare | The insurance brand behind many work and Marketplace plans | The Cigna Group | Uses the terms of the exact commercial plan. It is not the Bridge. |
| Express Scripts / Evernorth | Pharmacy-benefit and health-services businesses that administer benefits for many plans | The Cigna Group | May handle a commercial, retiree, or regular Part D benefit, but the federal Bridge has its own claim path. |
| HealthSpring | The brand now used for former Cigna Medicare plans acquired by HCSC | Health Care Service Corporation | Runs the member's regular Medicare plan. The Bridge runs separately. |
Sources: CMS BALANCE Model, CMS Medicare GLP-1 Bridge, The Cigna Group's Medicare-business sale announcement, and HealthSpring's 2026 transition notice.
Why so many people are confused right now
Several major changes happened close together. Each one made headlines with “Cigna,” “GLP-1,” “Medicare,” or “$50” in it.
| Date | What happened |
|---|---|
| March 19, 2025 | The Cigna Group completed the sale of its Medicare Advantage, Part D, supplemental, and CareAllies businesses to HCSC. |
| December 23, 2025 | CMS announced the BALANCE Model and a short-term Medicare GLP-1 Bridge. |
| January 1, 2026 | Former Cigna Medicare members began moving under the HealthSpring brand and receiving HealthSpring plan materials. |
| April 21, 2026 | CMS said BALANCE would not launch in Medicare Part D for 2027 and extended the Bridge through the end of 2027. |
| June 2026 | Cigna told its employees that weight-loss GLP-1 coverage in the Cigna Group Medical Plan would end. |
| July 1, 2026 | The Medicare GLP-1 Bridge went live, and Cigna's employee-plan change took effect. |
Put those together and it is easy to think “Cigna has a new $50 GLP-1 program.” It does not. But depending on your card, a $50 federal program may still be open to you.
For the full federal backstory, see CMS BALANCE Model GLP-1 Explained.
“My card said Cigna Medicare.” Who runs my plan now?
Cigna sold its Medicare Advantage, Medicare Part D, supplemental, and CareAllies businesses to Health Care Service Corporation (HCSC) on March 19, 2025. Those former Cigna Medicare plans now use the HealthSpring brand. HealthSpring says former Cigna Medicare customers received new HealthSpring plan materials and member ID cards for 2026. Cigna said Evernorth would continue providing pharmacy-benefit services and other solutions under service agreements for an agreed period after the sale.
If you had a Cigna Medicare plan in 2025, check the name on your current card instead of relying on old papers. HealthSpring's own website says it plainly: Cigna Medicare is now HealthSpring.
Card decoder: what the words on your card mean for this decision
| If you see… | It usually means… | Your lane |
|---|---|---|
| HealthSpring on a PDP or Medicare Advantage plan with drug coverage | A former Cigna Medicare drug plan or another current HealthSpring Part D plan | Medicare: Bridge for a qualifying weight-management claim, or regular Part D for a covered use |
| Old Cigna Healthcare Medicare papers from 2025 | The plan name used before the HealthSpring transition | Check your current HealthSpring card and current plan documents |
| Express Scripts or Evernorth only | A pharmacy-benefit administrator may sit behind a work plan, retiree plan, or Medicare plan | Look for Medicare, PDP, MA-PD, employer, or Marketplace wording before choosing a lane |
| A former employer's name + Medicare | It may be an employer or union retiree Medicare drug plan, often called an EGWP | Confirm it includes eligible Part D coverage; EGWPs can qualify for the Bridge |
| Cigna Healthcare + your employer, with no Medicare wording | A commercial work plan | Commercial Cigna lane |
| Cigna Group Medical Plan | Cigna's health plan for its own employees | Cigna employee lane |
| Your state's Medicaid program name | Medicaid | State Medicaid lane |
A HealthSpring Medicare Supplement or Medigap card by itself is not Part D drug coverage. You would need a separate eligible PDP for the Bridge.
Still not sure? Call the member number on the back of your card and ask one question: “Is my prescription benefit Medicare Part D, work-based, Marketplace, or Medicaid?”
The good news: a brand change does not block the $50 Bridge. Medicare runs the Bridge itself. You still need eligible Part D coverage and every clinical requirement.
Does HealthSpring or Cigna have to opt in to the $50 Medicare GLP-1 Bridge?
No. CMS runs the Medicare GLP-1 Bridge outside normal Part D coverage and payment, and Part D plan sponsors do not have to opt in. If you have an eligible Medicare drug plan and meet the health rules, your plan's brand does not decide Bridge access.
Here is how it works behind the scenes. CMS uses Humana as the central processor for Bridge approvals, claims, and pharmacy payments. Your HealthSpring plan does not pay the Bridge claim or make the Bridge eligibility decision.
Two more things that surprise people:
- You do not need a denial from your regular drug plan first. CMS says the pharmacy can send a qualifying weight-management claim straight to the Bridge.
- Your pharmacy does not have to sign up. CMS says pharmacies do not opt in to fill Bridge prescriptions.
Source: CMS information for providers and CMS information for pharmacies.
Who qualifies for the $50 Medicare GLP-1 Bridge?
You must be 18 or older, have an eligible Medicare drug plan, be prescribed an eligible drug for weight management, follow an ongoing diet and activity plan, and meet one of three BMI-and-health paths set by CMS. Your BMI is counted from when you first started GLP-1 treatment, not always from today. A prescriber has to confirm the facts.
Which Medicare plans count?
| Counts for the Bridge | Does not count unless you also have a separate eligible PDP |
|---|---|
| A standalone Medicare drug plan (PDP) | Private fee-for-service plans |
| Medicare Advantage with Part D through an HMO, HMO-POS, or local or regional PPO | Section 1876 cost plans |
| Special Needs Plans (SNPs) with Part D | Health care prepayment plans |
| Employer or union retiree Medicare drug plans (EGWPs) | PACE |
| LI NET | Fallback plans |
| Religious fraternal benefit plans |
Retiree plan through an old job? Do not assume you are left out. CMS's own FAQ says employer and union group waiver plans, or EGWPs, are eligible plan types. Many have an Express Scripts logo. Confirm that your plan includes Medicare Part D, then use the same Bridge process.
If you have both Medicare and Medicaid, you can use the Bridge too, as long as you are in an eligible Medicare drug plan and meet the other rules.
What are the three Bridge health paths?
All three paths require that the drug be used with an ongoing diet and activity plan.
| Path | Your BMI when GLP-1 treatment began | Plus at least one of these |
|---|---|---|
| 1 | 35 or higher | Nothing else is required for this path |
| 2 | 30 or higher | Heart failure with preserved ejection fraction (HFpEF); blood pressure above 140/90 despite two blood-pressure medicines; or chronic kidney disease stage 3a or worse |
| 3 | 27 or higher | Prediabetes; a past heart attack; a past stroke; or symptomatic peripheral artery disease |
Your starting BMI is the one that counts
This is the rule that saves people. CMS gives this example: someone who started a GLP-1 in September 2024 with a BMI of 37 and had a BMI of 34 in July 2026 still qualifies under Path 1. The prescriber should use the BMI from when treatment began.
So if the medicine is working and your BMI dropped, you have not automatically “lost” your place. Make sure the starting weight and BMI are in your records.
Who cannot use the Bridge for that prescription?
The Bridge is for qualifying weight-management use. A claim should go through regular Part D instead when the drug is prescribed for a use Part D can cover, including:
- Type 2 diabetes
- Moderate-to-severe obstructive sleep apnea
- Qualifying MASH with liver fibrosis
- An FDA-approved use to lower the risk of major cardiovascular events
Having one of those conditions does not erase every possible weight-management path by itself. The key question is why the drug is being prescribed and billed. Your prescriber should choose the correct lane.
Please be accurate on the form. Your prescriber must attest that the information is true, and CMS can check Medicare records. The goal is a correct form, not a creative one.
Does my prescriber have to be enrolled in Medicare?
No. CMS says a prescriber does not have to be enrolled in Medicare to prescribe a Bridge drug or submit the form. The prescriber cannot be on Medicare's preclusion list.
Think you fit a path? Check my $50 Bridge eligibility →
Our free checker walks through each path and shows what your prescriber needs to document. It does not promise approval.
Source: CMS information for providers.
Which GLP-1 drugs does the $50 Bridge cover?
The Medicare GLP-1 Bridge covers Foundayo, Wegovy injections and tablets, and the Zepbound KwikPen when they are prescribed for qualifying weight management. It does not cover Zepbound vials, Zepbound single-dose pens, Ozempic, Mounjaro, or compounded GLP-1 drugs.
| Medicine or form | Covered by the $50 Bridge? | Watch out for |
|---|---|---|
| Wegovy injection (semaglutide) | Yes | The claim still needs Bridge approval |
| Wegovy tablet (semaglutide) | Yes | The claim still needs Bridge approval |
| Foundayo tablet (orforglipron) | Yes | CMS added Foundayo after its 2026 FDA approval |
| Zepbound KwikPen (tirzepatide) | Yes | Only the KwikPen is included; pen needles are not covered by the Bridge |
| Zepbound single-dose pen | No | Do not assume every product sold under the Zepbound name is eligible |
| Zepbound vial | No | Cash-pay vials are not Bridge products |
| Ozempic | Not a Bridge product | Regular Part D may cover it for type 2 diabetes under the plan's rules |
| Mounjaro | Not a Bridge product | Regular Part D may cover it for type 2 diabetes under the plan's rules |
| Compounded semaglutide or tirzepatide | No | Compounded drugs are not FDA-approved and are not part of BALANCE or the Bridge |
The Zepbound trap: “Zepbound is covered” is only half true. The pharmacy must bill an eligible Zepbound KwikPen product. A vial or single-dose pen will not become Bridge-eligible just because the brand name is the same. More on this in our Zepbound KwikPen Bridge guide.
Sources: CMS Bridge provider FAQ and FDA concerns with unapproved GLP-1 drugs.
How do I start the $50 Bridge with HealthSpring or another Medicare plan?
Your prescriber sends the prescription to your pharmacy first. The pharmacy sends the claim to the Bridge, then sends a prior-authorization request back to your prescriber. CMS says the prior-authorization request usually reaches the prescriber within 24 to 72 hours, and a decision is sent within 72 hours after the completed form is submitted.
Prior authorization (PA) means the program checks the rules before it pays for the medicine. Your prescriber fills out the form, and the Bridge says yes or no.
The seven steps, in order
- You and your prescriber decide that an eligible Bridge medicine may fit your health and goals.
- Your prescriber sends the prescription to your pharmacy. CMS suggests adding the diagnosis code and a note that it is for the Medicare GLP-1 Bridge. That note is helpful, not required.
- The pharmacy sends the claim to the Bridge, not through your regular HealthSpring or Express Scripts Part D claim path.
- The pharmacy sends a PA request to your prescriber, usually within 24 to 72 hours.
- Your prescriber fills out the form and sends it. If no request arrives, the prescriber can use CMS's fax form.
- The Bridge sends a decision within 72 hours after it receives the completed PA. Your prescriber receives the decision, and CMS mails the beneficiary a letter.
- Approved? Pay $50 at the pharmacy for each 28- or 30-day fill. The approval can cover refills and dose changes through December 31, 2027, unless you switch to a different GLP-1 or lose eligibility.
Do not skip ahead. If your prescriber sends the PA before the pharmacy runs the Bridge claim, CMS says the system can return “patient not found.” The order matters.
The Express Scripts mix-up that looks like a denial
This one catches former Cigna Medicare members and some retiree-plan members. Federal law generally keeps drugs used only for weight loss outside regular Part D coverage. If the pharmacy sends a weight-management GLP-1 to the regular HealthSpring or Express Scripts Part D claim lane, it can be rejected.
That is not automatically a Bridge denial. It may be the wrong billing lane.
The Bridge has its own billing codes. Hand this line to your pharmacist:
Medicare GLP-1 Bridge: BIN 028918 · PCN MEDDGLP1BR
The pharmacy may ask for your Medicare Number. If it cannot find you, the last four digits of your Social Security number may help with an eligibility lookup.
What should I say to the pharmacy and prescriber?
To your pharmacy:
“This prescription is for weight management and may qualify for the Medicare GLP-1 Bridge. Please send the claim to the Bridge so the prior-authorization request can go to my prescriber.”
To your prescriber:
“Can we check whether this belongs in the Medicare GLP-1 Bridge? My BMI when I started was ___. Please send the prescription to the pharmacy first and wait for the Bridge prior-authorization request.”
Doctor and pharmacy checklist
Bring this to your appointment:
- [ ] Your Medicare card with your Medicare Number
- [ ] Your weight and BMI from when you started GLP-1 treatment, or today's values if you have not started
- [ ] Any qualifying condition in your chart: HFpEF, uncontrolled high blood pressure on two medicines, kidney disease stage 3a or worse, prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
- [ ] The exact medicine and form. For Zepbound, it must be an eligible KwikPen product.
- [ ] The name of the diet, activity, or lifestyle plan you are following
- [ ] Helpful numbers:
- Beneficiary: 1-800-MEDICARE (1-800-633-4227) for eligibility questions or PA status
- Prescriber: Medicare GLP-1 Bridge Call Center, 855-273-0102, weekdays 8 a.m. to 7 p.m. Eastern
- Pharmacy: Bridge Pharmacy Help Desk, 844-673-0910
For the form itself, see our guide to the Medicare Bridge prior-authorization form.
Sources: CMS information for providers, CMS information for pharmacies, and the CMS prior-authorization form.
What's the catch with the $50 Bridge?
The $50 price is real, but it sits outside your regular Medicare drug plan. It does not count toward your Part D deductible or out-of-pocket total, Extra Help does not lower it, and coupons cannot be used with it. The program is also set to end on December 31, 2027.
None of this is a dealbreaker for most people who qualify. $50 is still far below current cash prices. But you should know the rules before the first fill.
| Bridge rule | What it means for you |
|---|---|
| $50 for a 28- or 30-day supply | The Bridge copay stays $50 across eligible doses |
| Does not count toward your Part D deductible or TrOOP | It will not help you reach the Part D out-of-pocket threshold sooner |
| Does not appear on your Part D Explanation of Benefits | Keep your pharmacy receipts |
| Extra Help does not lower it | The Bridge price stays $50 even if your normal Part D copays are lower |
| Cannot be spread through the Medicare Prescription Payment Plan | You pay the $50 at the pharmacy |
| Coupons and discount cards cannot be combined with it | The Bridge must be billed as its own claim |
| One 28- or 30-day supply at a time | No 60- or 90-day Bridge fills |
| Pen needles for Zepbound KwikPen are not covered | You may have a small separate supply cost |
| No formal Bridge appeal | Your prescriber can resubmit corrected or new information, but there is no regular Bridge appeal track |
| Ends December 31, 2027 | No permanent replacement or continued $50 price has been confirmed |
When might regular Part D be the better lane?
If your GLP-1 is being prescribed for type 2 diabetes, moderate-to-severe obstructive sleep apnea, qualifying MASH, or an FDA-approved heart-risk use, it belongs in regular Part D rather than the Bridge. The practical upside is that covered Part D spending can count toward your Part D out-of-pocket total, and Extra Help can apply there. For some people, a covered Part D claim can cost less than $50.
Sources: Medicare.gov's weight-loss drug page and CMS pharmacy information.
What if my GLP-1 is for diabetes, sleep apnea, liver disease, or heart risk?
Then the prescription may belong in your regular Medicare drug plan, not the Bridge. CMS sends type 2 diabetes, moderate-to-severe obstructive sleep apnea, qualifying MASH, and an FDA-approved cardiovascular-risk use through Part D. The exact indication on the prescription and prior authorization matters.
| Why the GLP-1 is prescribed | Likely lane | Why |
|---|---|---|
| Weight management only | $50 Bridge, if every rule is met | This is the use the Bridge was built for |
| Type 2 diabetes | Regular Part D | Part D can cover this use under the plan's rules |
| Moderate-to-severe obstructive sleep apnea | Regular Part D | CMS directs the covered use through Part D |
| Noncirrhotic MASH with qualifying liver fibrosis | Regular Part D | CMS directs the covered use through Part D |
| Lowering major cardiovascular-event risk in a person with established cardiovascular disease | Regular Part D | The claim is for an FDA-approved Part D use, not weight management alone |
| Weight management, with a past heart attack or stroke | Bridge may still be possible under Path 3 | Only when the prescription is for weight management and the other rules are met |
| Weight management, with mild sleep apnea | Bridge may still be possible | CMS's Part D exclusion refers to moderate-to-severe obstructive sleep apnea |
Pick one lane on purpose. CMS says that if you are approved for the Bridge and later fill a GLP-1 through regular Part D, future Bridge refills can be rejected. Do not bounce between claim paths without your prescriber and pharmacy understanding why.
Do I need to switch Medicare plans this fall to keep the $50 Bridge?
No special “BALANCE plan” is required for the Bridge through 2027. CMS extended the Bridge through December 31, 2027. An approval can remain valid through that date unless you switch GLP-1 drugs, move to an ineligible plan type, or otherwise lose eligibility.
Earlier plans suggested some Bridge users might need to choose a BALANCE-participating Part D plan for 2027. That changed when CMS did not launch BALANCE in Part D for 2027 and extended the Bridge instead.
What this means during Medicare Open Enrollment, October 15 through December 7:
- Changing plans for another reason? Stay in an eligible Part D plan type if continued Bridge access matters. Compare the full plan—premiums, pharmacy network, doctors, and all drugs—not only the Bridge.
- No Medicare drug coverage right now? You are not Bridge-eligible without an eligible Medicare drug plan. Open Enrollment may be one chance to add or change coverage, depending on your situation.
Sources: CMS Bridge provider information, CMS pharmacy information, and Medicare.gov.
I have Cigna through work. Does BALANCE change my GLP-1 coverage?
No. BALANCE is a CMS model for Medicare and Medicaid, so it does not rewrite a Cigna work or Marketplace benefit. Your exact plan decides whether weight-management drugs are covered, and its drug policy decides what must be documented.
This is where most working-age Cigna members actually live. The good news: you do not have to wait on any federal model. Your answer exists today. It is in your plan.
First question: did your employer buy weight-loss coverage?
Two coworkers can both have “Cigna” on their cards and get opposite answers. Cigna's own policies say the plan document wins. If your plan excludes weight-loss drugs, a coverage policy showing when a drug could be approved does not add the missing benefit.
What do Cigna's own approval rules look like?
Cigna's current Foundayo policy, IP0206, is drug-specific and took effect September 1, 2026. Its revision history says the other weight-loss drugs moved to separate policies. Here is the Foundayo policy as a real example of what a commercial Cigna plan may ask for when the benefit includes the drug:
| Cigna asks for… | Foundayo policy details, effective September 1, 2026 |
|---|---|
| Age | 18 or older |
| Lifestyle effort | At least 3 months of behavior changes and a reduced-calorie diet before starting |
| BMI before any GLP-1 | 30 or higher, or 27 or higher with at least one listed weight-related condition |
| Initial approval | 8 months |
| Renewal | 1 year at a time after at least 5% loss from baseline weight |
| Controlling rule | The member's plan document and benefit terms supersede the coverage policy |
The policy's listed weight-related conditions include examples such as high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, COPD, fatty liver disease, and PCOS.
Notice the pattern: Cigna uses your BMI from before GLP-1 treatment, just like the Medicare Bridge. Keep that number in your chart.
Source: Cigna Foundayo coverage policy IP0206.
What if my employer uses EncircleRx?
EncircleRx is an Evernorth program some employers use for weight-management GLP-1 benefits. Its stated entry rules are stricter than the standard Cigna policy example:
- BMI 32 or higher, or BMI 27 or higher with two weight-related health conditions
- You must enroll in the required lifestyle program before the PA can be completed. Evernorth directs members to
express-scripts.com/healthsolutions. - If you are already using a GLP-1, the BMI recorded for the coverage process may be the number used for later reviews.
The exact plan terms still control. EncircleRx is not included in every Cigna or Express Scripts plan.
Source: Evernorth EncircleRx provider information.
Does Cigna cap Wegovy or Zepbound at $200?
Only if your employer chose that Evernorth option. Evernorth announced a benefit design that caps a member's monthly cost for Wegovy or Zepbound at no more than $200 and says that amount counts toward the deductible. It is not automatic for every Cigna or Express Scripts member.
Ask HR or the plan: “Did our plan adopt Evernorth's weight-loss medicine benefit with the $200 member cap?”
Before you pay anyone, check these five things
- Is the exact medicine and form on your plan's current drug list?
- Does the plan cover it for weight management, or only for another use?
- Is prior authorization required?
- Is step therapy required?
- What is the estimated cost at an in-network pharmacy?
You can check most of this in myCigna or your Express Scripts account. For the full drug-by-drug guide, see What GLP-1 Does Cigna Cover?.
Want someone to handle the commercial-insurance paperwork?
Here is the honest part first. Ro does not bill Medicare or run the $50 Bridge. A Medicare member may still be eligible for certain cash-pay options through Ro, but if you qualify for the Bridge, using your own prescriber and pharmacy for the $50 federal path will usually cost much less.
For a commercial Cigna or Marketplace plan, Ro's insurance concierge can verify benefits, submit prior-authorization paperwork, and communicate with the insurer. Ro says the broader concierge process often takes 1 to 3 weeks, while the insurer's PA review commonly takes about 1 to 2 weeks. Coverage is never guaranteed.
Provider-stated vs. source-checked on September 24, 2026
| Provider statement | What the current source page shows | What it means for you |
|---|---|---|
| “Get started for $39” | Ro lists $39 for the first membership month, then $74/month with annual prepay, $89/month for six months, $99/month for three months, or $149 month to month | The medicine is a separate charge; compare the total, not only the first month |
| Insurance support | Ro says its concierge verifies benefits and handles PA paperwork for eligible commercial coverage | Useful when paperwork—not a true exclusion—is the barrier |
| Which drugs Ro can run through insurance | Ro currently lists the Wegovy pen, Zepbound autoinjector pen, and Ozempic for its insurance pathway | Foundayo, Wegovy tablets, and Zepbound KwikPen are currently cash-pay through Ro, not part of Ro's insurance lane |
| Government insurance | Ro says Medicare, Medicare supplement, and TRICARE users may still qualify for certain cash-pay options; Medicaid users are not currently eligible for treatment on Ro | Ro is not a Bridge processor and cannot turn cash payments into Medicare claims |
| Sesame program price | Sesame lists $59/month with an annual subscription or $99 month to month, with medication charged separately | Sesame is a provider-choice alternative, not proof that Cigna covers the medicine |
Sources: Ro pricing, Ro insurance, and Sesame's weight-loss program.
Does that sound like your situation? Check whether Ro can work with my commercial Cigna coverage → (sponsored link)
Prefer to choose your own clinician? Compare Sesame Care → (sponsored link). Sesame's current program starts at $59 a month with an annual subscription or $99 month to month. Medication is extra.
Got a “no”? What kind was it, and what actually fixes it?
Not every “no” means the same thing. A plan exclusion, missing form, wrong billing lane, wrong drug form, and true failure to meet the rules each need a different response. Naming the problem first can save you weeks.
The RX Index “What kind of no?” decoder
| What you heard | What it usually means | What actually fixes it |
|---|---|---|
| “Excluded” or “not a covered benefit” on a work plan | The plan did not include weight-management drug coverage | Not a stronger PA. Confirm the exclusion, ask HR about future benefit changes, check for a different covered medical use, or compare cash options |
| “Prior authorization required” | The drug may be covered if you meet the plan's rules | A complete PA with the starting BMI, required lifestyle history, diagnosis, and other plan criteria |
| “Cannot complete PA” on an EncircleRx plan | The required lifestyle-program enrollment may be missing | Enroll in the required program, then restart the PA process |
| “Patient not found” from the Bridge | The PA was sent before the pharmacy established the Bridge claim | Pharmacy claim first, then prescriber PA |
| Pharmacy rejection on the regular HealthSpring or Express Scripts Part D card | A weight-management claim may have gone to the regular Part D lane | Ask the pharmacy to try the Bridge process and use BIN 028918 / PCN MEDDGLP1BR when appropriate |
| Bridge denial with wrong or missing information | The form was incomplete or inaccurate | Prescriber resubmits corrected or new information; there is no formal Bridge appeal |
| Bridge denial with accurate information | The prescription does not meet the current Bridge rules | Check regular Part D only for a legitimate covered use; otherwise compare non-Medicare cash paths |
| Bridge refill rejected after a Part D GLP-1 fill | The regular Part D fill ended Bridge eligibility | Ask the prescriber which lane is medically and financially correct, then stay in that lane |
| Claim fails for Zepbound | The pharmacy may be billing a vial or single-dose pen instead of an eligible KwikPen | Confirm the exact product and NDC; only the KwikPen is a Bridge product |
| Regular Part D denial | Normal Part D rules apply | Ask the plan about a coverage determination, exception, or appeal |
Not sure what your denial letter means? See my next step after a GLP-1 denial →
Tell the Find My GLP-1 Path tool what the letter says. It will point you toward the process that matches the message instead of giving you one generic answer.
What does each Cigna GLP-1 path cost per month?
Monthly costs can run from $50 through the Medicare Bridge, if you qualify, to hundreds of dollars for an FDA-approved medicine bought with cash. Current public offers start at $149 for some pills, while regular published Zepbound KwikPen prices reach $699 at higher doses. The hidden difference is whether the payment counts toward your deductible or out-of-pocket total.
This is the table nobody else puts in one place. Pay attention to the last column.
The RX Index Cigna GLP-1 Cost Ladder · verified September 24, 2026
| Path | Who can use it | What you pay | Counts toward a deductible or out-of-pocket total? |
|---|---|---|---|
| Medicare GLP-1 Bridge | Eligible Medicare drug-plan members with an approved qualifying weight-management claim | $50 per 28- or 30-day supply | No—not toward Part D deductible or TrOOP |
| Cigna work plan that covers the drug | Members whose plan includes the benefit and approves the claim | The plan's copay or coinsurance | Follows the plan's terms |
| Evernorth $200 cap | Only members whose employer adopted the option | No more than $200/month for Wegovy or Zepbound under that benefit | Yes, Evernorth says it counts toward the deductible |
| Manufacturer savings card | Usually eligible commercially insured patients who meet the card terms | Can lower a covered or noncovered commercial claim; exact amount varies by product | Depends on the plan and card terms; government-insured patients are generally excluded from commercial savings cards |
| FDA-approved cash price | People paying cash who meet the seller's and manufacturer program terms | Current public prices and offers start around $149 and can reach $699 at regular higher-dose prices | No toward Medicare or most insurance out-of-pocket totals |
| Ro membership, if you use Ro | Commercial-insurance and eligible cash-pay patients | $39 first month, then $74 to $149 per month depending on prepayment term | No; medication is a separate charge |
| Sesame membership, if you use Sesame | People who want to choose a clinician through Sesame | $59/month with annual subscription or $99 month to month | No; medication is a separate charge |
Current cash prices for FDA-approved GLP-1s, by dose
These are current public prices shown by Ro and the manufacturers on September 24, 2026. They can change. Offers have eligibility rules and end dates. If you use Ro, its membership fee is extra.
| Medicine | Current entry price | Higher doses and important terms |
|---|---|---|
| Wegovy tablet | $149/month for 1.5 mg | $199 for 4 mg; $299 for 9 mg and 25 mg |
| Foundayo tablet | $149/month for 0.8 mg; current offer also shows 2.5 mg at $149 | Current offer shows 5.5 mg at $199 and 9 mg or higher at $299; regular prices are higher at some doses and the offer can end |
| Wegovy pen | Current new-patient offer: $199/month for the first two fills at 0.25 mg and 0.5 mg | $349 for 1 mg to 2.4 mg; $399 for 7.2 mg Wegovy HD; the starter offer requires signup by December 31, 2026 |
| Zepbound KwikPen | $299/month for 2.5 mg | Regular prices: $399 at 5 mg, $499 at 7.5 mg, and $699 at 10–15 mg. A current purchase offer can lower 7.5–15 mg to $449 when its rules are met, including timely refills |
The takeaway: if you are on Medicare and qualify, $50 beats every listed cash option. If you have a work plan, a covered drug with plan cost-sharing or Evernorth's optional $200 cap may beat cash. Cash makes the most sense after you confirm the plan truly excludes the drug or the insurance path does not work.
Sources: Ro pricing, NovoCare Pharmacy terms, Zepbound savings and cash-price terms, and Foundayo savings information.
I work for Cigna. What happened to my GLP-1 coverage?
Cigna stopped covering GLP-1s prescribed for weight loss in its own employee health plan on July 1, 2026. Cigna said the change applied to its employees, not everyone with Cigna insurance, and that coverage for people with type 2 diabetes continued.
If this is you, we are sorry. It is a hard change, especially if the medicine was working.
“There's a difference between availability and affordability in drugs.” — Jama Mccloud, a Cigna employee speaking to WFSB in September 2026
Mccloud told WFSB that her monthly cost had been about $25 and would be close to $500 without the old benefit. More than 450 Cigna employees signed her petition. In a statement to the station, Cigna said the decision had been made with research and input from company leaders, including clinical leaders, and that the company would continue offering other weight-management support.
What the public reporting confirms:
- The change applied to GLP-1s prescribed for weight loss in the Cigna Group Medical Plan.
- It took effect July 1, 2026.
- Type 2 diabetes coverage continued.
- It did not automatically change the plans Cigna administers for other employers.
What are my realistic options as a Cigna employee?
- Check the exact reason for treatment. If the drug is prescribed for an FDA-approved use other than weight loss, ask the plan whether that use remains covered. Do not change the stated reason just to chase coverage.
- Ask your clinician about covered alternatives. A different medicine may be medically appropriate and included in the plan.
- Use the support Cigna says remains available. The company pointed employees to its weight-management resources, including Omada coaching.
- Compare current FDA-approved cash prices. Pills currently start at $149 a month before any telehealth membership fee. See the cost ladder above.
If staying on an FDA-approved GLP-1 matters most to you, see current FDA-approved cash options through Ro → (sponsored link). Ro lists the same published manufacturer cash prices shown above, but its membership fee is extra.
Source: WFSB's report and Cigna's quoted statement.
On Medicare but do not qualify for the Bridge? What is left?
You still have paths to check. Your Part D plan may cover a GLP-1 for a covered medical use. Medicare Part B covers obesity counseling when its rules are met. And some manufacturer or telehealth cash programs allow Medicare beneficiaries to self-pay, although the cash payment does not become a Medicare claim.
- A covered use in Part D. If type 2 diabetes, qualifying sleep apnea, qualifying MASH, or an FDA-approved cardiovascular use truly applies, your prescriber can pursue regular Part D coverage. See the diagnosis table above.
- Obesity behavioral therapy through Part B. Medicare covers obesity screening and behavioral counseling when your BMI is 30 or more. You pay nothing when the service is provided in a qualifying primary-care setting by a provider who accepts assignment.
- Cash through NovoCare for eligible products. NovoCare's terms allow people with government insurance to choose a cash-pay path under stated conditions. You cannot submit that cash purchase to Medicare or count it toward Part D out-of-pocket spending.
- Other FDA-approved cash programs. Terms differ by product, insurance status, dose, and offer. Read the current terms before assuming a displayed price applies to Medicare.
- Compare cash prices through official resources. Medicare.gov points beneficiaries to price-comparison options, including TrumpRx. A cash discount is separate from Medicare and does not count toward the Part D deductible or out-of-pocket total.
Not sure which path fits? Get my personalized Medicare action plan →
Sources: Medicare.gov weight-loss drugs, Medicare.gov obesity behavioral therapy, and NovoCare Pharmacy terms.
Does BALANCE help Medicaid members?
Only in a participating state and only under that state's final rules. CMS created a Medicaid BALANCE path, but Cigna does not decide whether a state joins. The state Medicaid agency does.
A few things to know:
- CMS's public participant field was listed as “N/A” when this page was checked. That is not proof that no state will participate. It means the public model page did not provide a usable participant count.
- If a state participates, CMS says the model can pair weight-management GLP-1 access with lifestyle support. Prior authorization and state eligibility rules still apply.
- It is not the $50 Bridge. The Bridge is a Medicare program. Medicaid cost-sharing follows state rules.
- State coverage changes. Do not rely on a national article alone when a state bulletin or formulary controls the answer.
Ask your state Medicaid office this exact question: “Has our state joined the CMS BALANCE Model for weight-management GLP-1s, and where is the current eligibility and prior-authorization policy?”
For the latest state-by-state work, see our Medicaid GLP-1 coverage tracker.
Source: CMS BALANCE Model.
What happens when the $50 Bridge ends after 2027?
The Medicare GLP-1 Bridge is scheduled to end on December 31, 2027. CMS says Bridge data may inform a later BALANCE path in Medicare Part D, but no permanent replacement, 2028 launch, or continued $50 price is confirmed.
| Confirmed | Not confirmed |
|---|---|
| The Bridge runs through December 31, 2027 | A permanent Medicare weight-management drug benefit |
| BALANCE did not launch in Medicare Part D for 2027 | A 2028 BALANCE start date |
| CMS is collecting Bridge data | Continued $50 pricing after 2027 |
| Current approvals can remain valid through the Bridge end date if eligibility is maintained | Automatic transfer of Bridge users into a future program |
Keep these records now:
- Your starting BMI and weight
- Your Bridge approval letter
- The diagnoses and relevant test results in your chart
- Your current medicine, exact form, and dose
- Pharmacy receipts
- Your prescriber's contact information
Then recheck the program and your plan during fall 2027 Open Enrollment. This page should be updated as soon as CMS announces a replacement, extension, or final Part D BALANCE path.
What did The RX Index actually verify?
We built this page from primary sources: CMS, Medicare.gov, Cigna's policy and SEC filing, HealthSpring, Evernorth, FDA, and each provider's own current pricing pages. We used WFSB only for the Cigna employee-plan change and quoted Cigna's own statement from that report. The lane matrix, cost ladder, card decoder, provider-stated table, and denial decoder are original editorial work assembled from those sources.
| What we checked | What it confirmed | Checked |
|---|---|---|
| CMS Medicare GLP-1 Bridge provider information | Dates, eligible plan types, clinical paths, starting-BMI rule, drug list, pharmacy-first order, timing, denial handling, and prescriber rules | Sept. 24, 2026 |
| CMS Medicare GLP-1 Bridge pharmacy information | $50 claim rules, one-month fills, BIN/PCN, Humana processing, no pharmacy opt-in, and Part D interaction | Sept. 24, 2026 |
| Medicare.gov “Weight loss drugs” | Consumer eligibility, Bridge cost treatment, approval period, Extra Help limits, and cash-price comparison | Sept. 24, 2026 |
| Medicare.gov “Obesity behavioral therapy” | Part B counseling at BMI 30+ and $0 cost when assignment and setting rules are met | Sept. 24, 2026 |
| CMS BALANCE Model page | Model scope, Medicaid participation structure, lifestyle support, and Medicare Part D status | Sept. 24, 2026 |
| The Cigna Group SEC-filed press release | March 19, 2025 sale of Medicare businesses to HCSC and continuing Evernorth service agreements | Sept. 24, 2026 |
| HealthSpring's 2026 transition notice | Former Cigna Medicare customers moved under HealthSpring and received new plan materials/cards | Sept. 24, 2026 |
| Cigna Foundayo policy IP0206 | Effective date, age, lifestyle, BMI, initial approval, renewal, and plan-document control | Sept. 24, 2026 |
| Evernorth EncircleRx provider page | BMI entry rules and lifestyle-program enrollment before PA | Sept. 24, 2026 |
| Evernorth $200 benefit announcement | Optional employer benefit and deductible treatment | Sept. 24, 2026 |
| FDA GLP-1 compounding information | Compounded drugs are not FDA-approved and are not reviewed before marketing in the same way as approved products | Sept. 24, 2026 |
| Ro pricing and insurance pages | Membership prices, current cash prices, insurance-supported drugs, PA help, and government-insurance limits | Sept. 24, 2026 |
| Sesame's current program page | $59 annual-plan monthly price, $99 month-to-month price, provider choice, and medication charged separately | Sept. 24, 2026 |
| Lilly Zepbound terms | Regular KwikPen prices and the conditions on the current $449 higher-dose offer | Sept. 24, 2026 |
| NovoCare Pharmacy terms | Conditions for government-insured patients who choose to self-pay | Sept. 24, 2026 |
| WFSB report with Cigna's statement | Cigna employee-plan date, scope, diabetes exception, petition, and company response | Sept. 24, 2026 |
What we did not verify: your personal coverage, a specific state's Medicaid participation, your plan's current pharmacy manager, or whether a clinician will prescribe a medicine for you. We did not enroll in any program. This page explains coverage processes. It does not diagnose a condition, decide whether a medicine is right for you, or promise approval.
Who, how, and why: This page was written by The RX Index Editorial Team. We compared current CMS and Medicare rules with Cigna, Evernorth, HealthSpring, FDA, and provider materials, then sorted them by the type of plan a reader actually has. It exists because a federal model, a private Cigna plan, a pharmacy-benefit company, and a renamed Medicare plan can sound like one thing—and mixing them up can cost people weeks and money.
Cigna BALANCE Model GLP-1 FAQ
Is Cigna part of the BALANCE Model?
No. CMS runs the BALANCE Model for Medicare and Medicaid. Cigna work and Marketplace plans are separate commercial benefits, and CMS did not launch BALANCE in Medicare Part D for 2027.
Is HealthSpring the same as Cigna?
Not exactly. HealthSpring is the current brand for former Cigna Medicare plans acquired by Health Care Service Corporation in 2025. Former Cigna Medicare customers received HealthSpring plan materials and cards for 2026.
Does my HealthSpring or Cigna plan have to approve the $50 Bridge?
No. The Bridge operates outside normal Part D payment, so the plan sponsor does not opt in or make the Bridge eligibility decision. The pharmacy and prescriber still have to use the Bridge process, and you must meet every rule.
Can I use the $50 Bridge with Cigna through my job?
Not with a commercial work plan alone. The Bridge requires an eligible Medicare drug plan, such as a standalone PDP, an eligible Medicare Advantage plan with Part D, or an eligible employer or union retiree Medicare drug plan.
Does the Bridge cover Ozempic or Mounjaro?
No. The Bridge covers Foundayo, Wegovy injections and tablets, and Zepbound KwikPen for qualifying weight management. Ozempic and Mounjaro may be covered through regular Part D for type 2 diabetes under the plan's rules.
Does the Bridge cover every kind of Zepbound?
No. Only Zepbound KwikPen is included. Zepbound vials and single-dose pens are not Bridge products, and the Bridge does not cover the pen needles.
Does the $50 count toward my Part D out-of-pocket total?
No. The Bridge is outside regular Part D. The $50 does not count toward the Part D deductible or TrOOP and does not appear on the normal Part D Explanation of Benefits.
Does Extra Help lower the $50 Bridge copay?
No. Extra Help does not lower the Bridge copay, the Medicare Prescription Payment Plan cannot spread it over the year, and coupons or discount cards cannot be combined with the Bridge claim.
I pay cash for Wegovy. Can I switch to the $50 Bridge?
You can start the Bridge process for future fills if you have eligible Medicare drug coverage and meet every Bridge rule. The pharmacy must submit the Bridge claim first, then the prescriber completes the PA. The Bridge does not reimburse past cash purchases.
Do I need a Part D denial before using the Bridge?
No. CMS says a prior denial from the regular Part D plan is not required. The pharmacy can send an eligible weight-management claim directly through the Bridge process.
Can I appeal a Bridge denial?
There is no formal Bridge appeal process. Your prescriber can resubmit corrected or new information. A denial from your regular Part D plan uses the plan's normal coverage-determination and appeal process instead.
Can a telehealth prescriber send my Bridge prior authorization?
CMS says the prescriber does not have to be enrolled in Medicare, but cannot be on Medicare's preclusion list. The telehealth service still has to be willing and able to send the prescription to a pharmacy and complete the Bridge form.
Does Medicaid get the same $50 price?
No. The $50 Bridge is a Medicare program. Medicaid access under BALANCE depends on state participation and state rules, including any cost-sharing.
Are compounded GLP-1 drugs part of BALANCE or the Bridge?
No. The Bridge covers specified FDA-approved brand products and forms. Compounded drugs are not FDA-approved and are not included in the Bridge.
Why did Cigna stop covering weight-loss GLP-1s for its own employees?
Cigna told employees that access and options had expanded since the company began covering them for weight loss in 2024. The company later told WFSB that it made the change after research and input from company leaders, including clinical leaders. The July 1, 2026 change applied to Cigna's employee plan, not every Cigna customer.
What happens after December 31, 2027?
The Bridge is scheduled to end. CMS says the data may inform a possible later BALANCE path in Medicare Part D, but no replacement, 2028 start, or continued $50 price is confirmed.
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz →
Your situation changes the answer: Find My GLP-1 Path
The right GLP-1 provider is not the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved medicine or are considering a compounded option, your preferred form, and your budget. The RX Index's Find My GLP-1 Path tool sorts those facts before it shows you a treatment path.
- What it asks: your state, insurance, medicine preference, budget, and support needs
- What you get: your likely coverage lane, a matched shortlist of treatment paths with verified pricing, and the questions to ask next
- Cost: free · about 2 minutes · no signup
Sources
- CMS: Medicare GLP-1 Bridge · Information for Providers · Information for Pharmacies · Prior Authorization Form
- CMS: BALANCE Model
- Medicare.gov: Weight loss drugs · Obesity behavioral therapy
- The Cigna Group: SEC-filed sale announcement, March 19, 2025
- HealthSpring: HealthSpring.com · Welcome to HealthSpring, January 1, 2026
- Cigna: Foundayo coverage policy IP0206, effective September 1, 2026
- Evernorth: EncircleRx provider page · $200 monthly cap benefit option
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- WFSB: Cigna employee-plan change and Cigna statement, September 2, 2026
- NovoCare: Pharmacy cash/self-pay terms
- Lilly: Zepbound savings and cash-price terms · Foundayo
- Ro: Pricing · Insurance
- Sesame: Online weight-loss program
Last verified: September 24, 2026 · Next scheduled review: October 24, 2026, or sooner if CMS changes the Bridge or BALANCE, Cigna changes a policy, or a listed price or offer changes.
Related guides
- CMS BALANCE Model GLP-1 Explained
- Medicare GLP-1 Bridge Tracker
- Medicare GLP-1 Bridge Eligibility
- Medicare Bridge Prior Authorization Form
- What GLP-1 Does Cigna Cover?
- Does Cigna Cover Ozempic?
- GLP-1 Providers That Accept Cigna
- GLP-1 Providers That Accept Express Scripts
- Medicaid GLP-1 Coverage by State
- GLP-1 Employer Coverage Tracker
The RX Index: Independent guidance for choosing your GLP-1 path.